WHO ICTRP trial
Role of Sentinel Lymph Node Evaluation Using Indocyanine Green in the Management…
CTRI/2023/03/051086 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2023/03/051086 |
|---|---|
| Public title | Role of Sentinel Lymph Node Evaluation Using Indocyanine Green in the Management of Early Stage Gynecological Cancers |
| Scientific title | Evaluation of Indocyanine Green (ICG) and Handheld Fluorescence Imager in the Management of Early Stage Gynecological Cancers |
| Primary sponsor | Indian Council of Medical Research, New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 2: C549- Malignant neoplasm of corpus uteri, unspecified Health Condition 3: C579- Malignant neoplasm of female genital organ, unspecified Health… |
| Interventions | Intervention1: Sentinel node detection: ICG will be injected during surgery. For cancers of endometrium and cervix: Four milliliters of 1.25 mg/ml ICG solution will be injected into the cervix divided into the 3- and 9-oclock positions… |
| Registration date | Mar 27, 2023 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: